Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig M Kessler

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Seminars in Thrombosis and Hemostasis|October 9, 2018
Treatment of Venous Thromboembolism in Elite Athletes: A Suggested Approach to Individualized AnticoagulationBassel Nazha, Bhavi Pandya, Alex C Spyropoulos, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 11, 2012
Use of objective efficacy criteria for evaluation of von Willebrand factor/factor VIII concentratesCraig M Kessler, Jerzy Windyga, Bruce A Schwartz, et al.
Pediatric Blood & Cancer|January 22, 2013
Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: the experience of the Hemostasis and Thrombosis Research Society (HTRS) Registry (2004-2008)Ellis J Neufeld, Kapil Saxena, Craig M Kessler, et al.
Acta Obstetricia Et Gynecologica Scandinavica|October 28, 2006
Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical useSlawomir Sobieszczyk, Grzegorz H Breborowicz, Viliyan Platicanov, et al.
American Journal of Hematology|February 19, 2016
A second retrospective database analysis confirms prior findings of apparent increased cardiovascular comorbidities in hemophilia A in the United StatesThomas J Humphries, Alice Ma, Craig M Kessler, et al.
European Journal of Applied Physiology|August 7, 2007
Fibrinolytic markers and vasodilatory capacity following acute exercise among men of differing training statusTracy Baynard, Helena M Jacobs, Craig M Kessler, et al.
Thrombosis Research|October 27, 2009
Flow-based measurements of von Willebrand factor (VWF) function: binding to collagen and platelet adhesion under physiological shear rateBirte Fuchs, Ulrich Budde, Andrea Schulz, et al.
JTO Clinical and Research Reports|September 30, 2021
Acquired Coagulopathy With Immune Checkpoint Inhibitors: An Underrecognized Association Between Inflammation and CoagulationJacinth J Joseph, Arun Rajan, James L Gulley, et al.
Thrombosis and Haemostasis|July 5, 2011
The pharmacokinetic diversity of two von Willebrand factor (VWF)/ factor VIII (FVIII) concentrates in subjects with congenital von Willebrand disease. Results from a prospective, randomised crossover studyCraig M Kessler, Ken Friedman, Bruce A Schwartz, et al.
American Journal of Hematology|September 25, 2004
Monoclonal gammopathy in extranodal marginal zone lymphoma (ENMZL) correlates with advanced disease and bone marrow involvementEkatherine Asatiani, Philip Cohen, Metin Ozdemirli, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Seminars in Thrombosis and Hemostasis|October 9, 2018
Treatment of Venous Thromboembolism in Elite Athletes: A Suggested Approach to Individualized AnticoagulationBassel Nazha, Bhavi Pandya, Alex C Spyropoulos, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 11, 2012
Use of objective efficacy criteria for evaluation of von Willebrand factor/factor VIII concentratesCraig M Kessler, Jerzy Windyga, Bruce A Schwartz, et al.
Pediatric Blood & Cancer|January 22, 2013
Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: the experience of the Hemostasis and Thrombosis Research Society (HTRS) Registry (2004-2008)Ellis J Neufeld, Kapil Saxena, Craig M Kessler, et al.
Acta Obstetricia Et Gynecologica Scandinavica|October 28, 2006
Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical useSlawomir Sobieszczyk, Grzegorz H Breborowicz, Viliyan Platicanov, et al.
American Journal of Hematology|February 19, 2016
A second retrospective database analysis confirms prior findings of apparent increased cardiovascular comorbidities in hemophilia A in the United StatesThomas J Humphries, Alice Ma, Craig M Kessler, et al.
European Journal of Applied Physiology|August 7, 2007
Fibrinolytic markers and vasodilatory capacity following acute exercise among men of differing training statusTracy Baynard, Helena M Jacobs, Craig M Kessler, et al.
Thrombosis Research|October 27, 2009
Flow-based measurements of von Willebrand factor (VWF) function: binding to collagen and platelet adhesion under physiological shear rateBirte Fuchs, Ulrich Budde, Andrea Schulz, et al.
JTO Clinical and Research Reports|September 30, 2021
Acquired Coagulopathy With Immune Checkpoint Inhibitors: An Underrecognized Association Between Inflammation and CoagulationJacinth J Joseph, Arun Rajan, James L Gulley, et al.
Thrombosis and Haemostasis|July 5, 2011
The pharmacokinetic diversity of two von Willebrand factor (VWF)/ factor VIII (FVIII) concentrates in subjects with congenital von Willebrand disease. Results from a prospective, randomised crossover studyCraig M Kessler, Ken Friedman, Bruce A Schwartz, et al.
American Journal of Hematology|September 25, 2004
Monoclonal gammopathy in extranodal marginal zone lymphoma (ENMZL) correlates with advanced disease and bone marrow involvementEkatherine Asatiani, Philip Cohen, Metin Ozdemirli, et al.
Pageof 9